A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults.

NCT07366866 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Disease

Interventions

DRUG: GenSci136
DRUG: Placebo

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.